Skip to main content
Premium Trial:

Request an Annual Quote

Protagen Raises $1.5M in Third Round of Financing

NEW YORK (GenomeWeb News) – Dortmund, Germany-based Protagen today said that it has raised €1 million ($1.5 million) in a third round of financing with private investors.
 
Protagen said it would use the funds to expand its protein biochips business. The firm said it has developed a unique protein biochip technology package, called UNIarray, for the discovery and validation of biomarkers.
 
It also is working on diagnostics for multiple sclerosis, rheumatoid arthritis, juvenile idiopathic arthritis, and Alzheimer’s disease.
 
Investors in this round of financing included Munich-based MIG AG and Co KG Beteiligungsfonds 3, S-Venture Capital Dortmund, and Kreditanstalt für Wiederaufbau.
 
Protagen has raised a total of €5.3 million since 2004.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.